Aggressive medical management of coronary artery disease versus mechanical revascularization

Current Atherosclerosis Reports

Volumn 5, Issue 2, 2003, Pages 118-123

  Chiquette, Elaine ^a   Chilton, Robert ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CHOLESTEROL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LISINOPRIL; LOSARTAN; METOPROLOL; NITRATE; SIMVASTATIN;

ANGIOCARDIOGRAPHY; ATHERECTOMY; BLOOD PRESSURE REGULATION; CALORIC RESTRICTION; CLINICAL PROTOCOL; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; CORONARY STENT; DRUG ELUTING STENT; DYSLIPIDEMIA; EQUIPMENT DESIGN; EXERCISE; HEART MUSCLE ISCHEMIA; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INTERMETHOD COMPARISON; LIFESTYLE; LOW FAT DIET; MORBIDITY; MORTALITY; OBESITY; PATIENT EDUCATION; PERCUTANEOUS CORONARY INTERVENTION; PHYSICAL ACTIVITY; RESTENOSIS; REVIEW; RISK MANAGEMENT; RISK REDUCTION; SECONDARY PREVENTION; SILENT MYOCARDIAL ISCHEMIA; SMOKING CESSATION; STABLE ANGINA PECTORIS; SURGICAL APPROACH; SURGICAL TECHNIQUE; SURVIVAL; SYMPTOM; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; WEIGHT REDUCTION; COMPARATIVE STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DIABETES MELLITUS; HEART MUSCLE REVASCULARIZATION; HYPERLIPIDEMIA; METHODOLOGY; RISK FACTOR; SMOKING;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; DIABETES COMPLICATIONS; DIABETES MELLITUS; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MYOCARDIAL REVASCULARIZATION; OBESITY; RISK FACTORS; SMOKING;

EID: 0037645449     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-003-0083-1     Document Type: Review

References (22)

1. Department of Veterans Affairs Cooperative Studies Program #424. Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE). http://www.couragetrial.gov. Accessed on October 15, 2002.
2. Parisi AF, Folland ED, Hartigan P: A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators. N Engl J Med 1992, 326:10-16.
3. Hartigan PM: ACME (Angioplasty Compared to Medicine): five year clinical and economic outcomes. The 47th Scientific Sessions of the American College of Cardiology. Atlanta, Georgia; 1998.
4. Hueb WA, Belotti G, de Oliveira SA, et al.: The Medicine, Angioplasty or Surgery Study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenosis. J Am Coll Cardiol 1995, 26:1600-1605.
5. RITA-2 trial participants: Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment ofAngina (RITA-2). Lancet 1997, 350:461-468.
6. Pitt B, Waters D, Brown WV, et al., for the Atorvastatin versus Revascularization Treatment Investigators: Aggressive lipid lowering therapy compared with angioplasty in stable coronary artery disease. N Engl J Med 1999, 341:70-76.
7. Murphy ML, Hultgren HN, Detre K, et al.: Veterans Administration Cooperative Study. Treatment of chronic stable angina: a preliminary report of survival data of the Randomized Veterans Administration Cooperative Study. N Engl J Med 1977, 297:621-627.
8. European Coronary Surgical Study Group: Coronary artery bypass surgery in satbel angina pectoris: survival at two years. Lancet 1979, i:889-893.
9. CASS Principal Investigators: Coronary Artery Surgery Study (CASS): a randomized trial of coronary artery bypass surgery: survival data. Circulation 1983, 68:939-950.
10. NHLBI Obesity Task Force: Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults - the Evidence Report. Obes Res 1998, 6(suppl 2):51S-209S.
11. Jacobs D, Blackburn H, Higgins M, et al.: Report of the conference on low blood cholesterol: mortality associations. Circulation 1992, 86:1046-1060.
12. Chen Z, Peto R, Collins R, et al.: Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. BMJ 1991, 303:276-282.
13. Superko HR, Krauss RM: Coronary artery disease regression: convincing evidence for the benefit of aggressive lipoprotein management. Circulation 1994, 90:1056-1069.
14. Smilde TJ, van Wissen S, Wollersheim H, et al.: Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolemia (ASAP): a prospective, randomized, double-blind trial. Lancet 2001, 357:577-581.
15. American Diabetes Association: Implications of the United Kingdom Prospective Diabetes Study. Diabetes Care 2001, 24:S28-S32.
16. Gibbons RJ, Chatterjee K, Daley J, et al.: ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force of the Practice Guidelines. Circulation 1999, 99:2829-2848.
17. Ridker PM, Manson JE, Gaziano JM, et al.: Low dose aspirin therapy for chronic stable angina. A randomized placebo controlled clinical trial. Ann Intern Med 1991, 114:835-839.
18. Antiplatelet Trialists Collaboration: Collaborative overview of randomized trials of antiplatelet therapy-I: prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories ofpatients. BMJ 1995, 308:81-106.
19. Pepine CJ, Cohn PF, Deedwania PC, et al.: Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The atenolol silent ischemia study (ASISY). Circulation 1994, 90:762-768.
20. Dargie HJ, Ford I, Fox KM: Total ischemic burden European trial (TIBET). Effects of ischemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. The TIBET Study Group. Eur Heart J 1996, 17:104-112.
21. Savonitto S, Ardissiono D, Egstrup K, et al.: Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris. Results of the International Multicenter Angina Exercise (IMAGE) study. J Am Coll Cardiol 1996, 27:311-316.
22. Regar E, Serruys PW, Bode C, et al., on Behalf of the RAVEL Study Group: Angiographic findings of the multicenter Randomized Study with the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL). Circulation 2002, 106:1949-1956.